.png){kind=icon}
返回
Synvisc perisynovitis
.png){kind=icon}
PRE
AI
DOI：10.1080/00313020120083296.png)
.png){kind=icon}
原文求助.png){kind=icon}
分享.png){kind=icon}
收藏
摘要
En 中文
Synvisc (hylan G-F 20) is a high molecular weight hyaluronan which is manufactured from chicken combs. It is currently one of the options used in the treatment of severe osteoarthritis of the knee joint. Synvisc is directly injected into the diseased joint, where it provides elasticity and viscosity. Published experience suggests than Synvisc is a safe and well-tolerated material with occasional mild local reactions but no long-term adverse sequelae. This article describes a case of Synvisc-related granulomatous inflammation in the perisynovial adipose tissue. To our knowledge, this is the first histological account of tissue reaction to Synvisc.
Keyword:
synovitis
hyaluronan
Synvisc
hylan G-F 20
AI总结
对已上传原文的论文进行重点信息的提取，主要内容包括：简要概述、研究摘要、背景介绍、关键亮点、图文解析、展望与总结。
期刊
IF:
3
论文数:
4.2K
被引数:
4.1K
机构
暂无机构信息
引用论文
A risk-benefit assessment of injections of hyaluronan and its derivatives in the treatment of osteoarthritis of the knee.png)
DRUG SAFETY
DRUG SAFETYIF3.8
PREAI
分享收藏